Concepedia
Statistics
Publications
15
Citations
558
H-Index
13
Active since
1984
Affiliations
Inserm(Current)
Centre Hospitalier Universitaire de Montpellier
Sorbonne Université
Hôpital Lapeyronie
Assistance Publique – Hôpitaux de Paris
Jean-David Cohen is an author at Inserm specializing in rheumatology, rheumatoid arthritis, and inflammation.
Publications per year
1984–2022
Infliximab to etanercept switch in patients with spondyloarthropathies and psoriatic arthritis: preliminary data.
Caroline Delaunay, Valérie Farrenq, A Marini-Portugal et al. · PubMed · 2005 · 74 citations
Medicine, Immunology, Pharmacotherapy +16
Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases
Coline Faivre, A. Villani, F. Aubin et al. · Journal of the American Academy of Dermatology · 2016 · 71 citations
Veterinary Medicine, Pharmacology, Pharmacotherapy +11
Protein biochip array technology for cytokine profiling predicts etanercept responsiveness in rheumatoid arthritis
S Fabre, Anne‐Marie Dupuy, Nadège Dossat et al. · Clinical & Experimental Immunology · 2008 · 69 citations · Full text
Life Sciences, Clinical Sciences, Immunology +17
Patients’ information and perspectives on biosimilars in rheumatology: A French nation-wide survey
Léa Frantzen, Jean-David Cohen, Sonia Tropé et al. · Joint Bone Spine · 2019 · 50 citations
Medicine, Clinical Sciences, Internal Medicine +12
Estimation of the Bath Ankylosing Spondylitis Disease Activity Index cutoff for perceived symptom relief in patients with spondyloarthropathies.
Jean-David Cohen, Patrick Cunin, Valérie Farrenq et al. · PubMed · 2006 · 47 citations
Nursing, Health Sciences, Internal Medicine +15
1–5 of 15